(Q34451914)

2 August 2017

1 reference

title

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours (English)

1 reference

2 August 2017

1 reference

Muehlenweg B

1

1 reference

2 August 2017

Sperl S

2

1 reference

2 August 2017

Magdolen V

3

1 reference

2 August 2017

Schmitt M

4

1 reference

2 August 2017

Harbeck N

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

683-691

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: a review

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Generation and characterization of urokinase receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Aromatic amidines. Comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Amiloride selectively inhibits the urokinase-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

3-Amidinophenylalanine-based inhibitors of urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Discovering novel ligands for macromolecules using X-ray crystallographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.4.683

21 January 2018

Identifiers

DOI

10.1517/14712598.1.4.683

1 reference

2 August 2017

1 reference